Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic disease

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 348-352

  Rein, Philipp ^a,c   Saely, Christoph H ^a,b,c   Muendlein, Axel ^a   Vonbank, Alexander ^a,b,c   Drexel, Heinz ^a,b,c,d  

^a Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^b Academic Teaching Hospital Feldkirch   (Austria)

^c PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Angiography; Atherosclerosis; Coronary; Coronary artery disease; EGFR; Kidney; Renal disease

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; KIDNEY; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; THROMBOSIS; TREATMENT OUTCOME;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 77954309404     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.031     Document Type: Article

References (31)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
2. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
3. Shlipak M.G., Simon J.A., Grady D., et al. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 2001, 38:705-711.
4. Drexel H., Aczel S., Marte T., et al. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?. Diabetes Care 2005, 28:101-107.
5. Saely C.H., Koch L., Schmid F., et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006, 29:901-907.
6. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998, 15:539-553.
7. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
8. Drexel H., Amann F.W., Rentsch K., et al. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 1992, 70:436-440.
9. Drexel H., Amann F.W., Beran J., et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994, 90:2230-2235.
10. Rule A.D., Larson T.S., Bergstralh E.J., et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004, 141:929-937.
11. Risch L., Saely C.H., Neyer U., et al. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care--an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates. Clin Chim Acta 2007, 378:71-77.
12. Berg U.B. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transpl 2006, 21:2577-2582.
13. Flack J.M., Neaton J.D., Daniels B., et al. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis 1993, 21:31-40.
14. Shlipak M.G., Stehman-Breen C., Vittinghoff E., et al. Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?. Am J Kidney Dis 2004, 43:37-44.
15. Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002, 106:974-980.
16. Walsh C.R., O'Donnell C.J., Camargo C.A., et al. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002, 144:1003-1011.
17. Shlipak M.G. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 2003, 138:917-924.
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-266.
19. Rifkin D.E., Shlipak M.G., Katz R., et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008, 168:2212-2218.
20. Flack J.M., Peters R., Shafi T., et al. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol 2003, 14:S92-S98.
21. US Renal Data System USRDS 2001 Annual data report: Atlas of end-stage renal disease in the United States 2001, National Institutes of Health, Niational Institute of Diabetes and Digestive and Kidney Disease, Bethesda (MD).
22. Hostetter T.H. Prevention of the development and progression of renal disease. J Am Soc Nephrol 2003, 14:S144-S147.
23. Fioretto P., Solini A. Antihypertensive treatment and multifactorial approach for renal protection in diabetes. J Am Soc Nephrol 2005, 16(Suppl 1):S18-S21.
24. Hostetter T.H. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004, 351:1344-1346.
25. Endemann D.H., Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 2004, 15:1983-1992.
26. Passauer J., Pistrosch F., Bussemaker E., et al. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J Am Soc Nephrol 2005, 16:959-965.
27. Schiffrin E.L., Touyz R.M. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004, 287:H435-H446.
28. Ketteler M., Schlieper G., Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 2006, 47:1027-1034.
29. Johnson R.C., Leopold J.A., Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006, 99:1044-1059.
30. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004, 351:1285-1295.
31. Lindner A., Charra B., Sherrard D.J., et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974, 290:697-701.